Boston, MA and Munich, Germany – SIRION Biotech, a leading viral vector platform company known for creating high quality viral vector solutions for industry and academic partners, today announced its commitment to open a new office in the vicinity of Boston. The announcement was made during the 2015 BIO International Convention taking place this week in Philadelphia, Pennsylvania.
SIRION is working with the Massachusetts Life Sciences Center (MLSC) to locate lab and office space for the Company, which will prove to be a pivotal step in SIRION’s U.S. expansion. SIRION’s office in the Boston area will allow direct access to Massachusetts’ vibrant life science community, which includes an increasing number of biotechnology companies and academic researchers working to develop gene therapies and vaccines for a range of diseases.
(From left) Representative Jeffrey N. Roy (D-Franklin), Senator Michael Rodriques (D-Westport), MLSC Vice President for Industry Relations and Programs Pamela Norton, and President & CEO of MassBio Robert K. Coughlin (far right) join Chief Operating Officer Dieter Lingelbach (fourth from left) and other members of the SIRION Biotech team to announce the German company’s decision to open an office in Massachusetts. The announcement was made at the 2015 BIO International Convention in Philadelphia, Pennsylvania.